NCT07547241 Comparison of Two Surgical Methods (Winograd vs. Sleeve Method) in the Treatment of Ingrown Toenail.
| NCT ID | NCT07547241 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pakistan Institute of Medical Sciences |
| Condition | Ingrown Toenail (Onychocryptosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 312 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 312 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial aims to compare the recurrence rates of two surgical techniques-Winograd procedure and sleeve (gutter) method-in the treatment of ingrown toenails (onychocryptosis). A total of 312 nails will be randomized into two groups, with patients receiving either the Winograd procedure or sleeve method. Participants will be followed for 30 days post-intervention to assess recurrence and other clinical outcomes. The study seeks to determine the more effective treatment modality for reducing recurrence in a tertiary care setting.
Eligibility Criteria
Inclusion Criteria: * Patients presenting with ingrown toenail (onychocryptosis) * Patients for whom surgical intervention is indicated * Age between 12 and 75 years * Both male and female participants * Patients willing to provide informed consent Exclusion Criteria: * Patients with diabetes mellitus * Patients with peripheral vascular disease * Immunocompromised patients * Patients with coagulopathy * Patients receiving chemotherapy * Patients with localized infection or abscess at the surgical site * Patients with previously treated or recurrent ingrown toenail * Patients presenting with delayed complications of prior ingrown toenail surgery
Contact & Investigator
Dr Muhammad Fahad Ali, Mbbs
PRINCIPAL INVESTIGATOR
Pakistan Institute of Medical Sciences
Frequently Asked Questions
Who can join the NCT07547241 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 75 Years, studying Ingrown Toenail (Onychocryptosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07547241 currently recruiting?
Yes, NCT07547241 is actively recruiting participants. Contact the research team at joyafahad@gmail.com for enrollment information.
Where is the NCT07547241 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07547241 clinical trial?
NCT07547241 is sponsored by Pakistan Institute of Medical Sciences. The principal investigator is Dr Muhammad Fahad Ali, Mbbs at Pakistan Institute of Medical Sciences. The trial plans to enroll 312 participants.